Equities

Quest Pharmatech Inc

QPT:CVE

Quest Pharmatech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.02
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-76.47%
  • Beta0.2627
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-22.26m
  • Incorporated1996
  • Employees0.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Intellipharmaceutics International Inc1.23m-4.32m2.65m33.00------2.15-0.1305-0.13050.0372-0.52950.6027--3.37---211.39-132.15-----88.96---350.72-499.37---19.36-------58.7543.78------
Aequus Pharmaceuticals Inc215.21k-2.88m2.65m12.00------12.32-0.0217-0.02170.0016-0.03730.20941.2311.31---280.53-97.96---293.3158.26---1,339.39-141.530.0724-16.307.83---81.53-28.977.64------
Radient Technologies Inc3.15m-11.30m2.70m33.00------0.8584-0.0216-0.02160.006-0.02780.11081.566.00---39.76-67.36---118.27-3.911.66-359.00-534.110.0251-3.58----45.4965.3069.41--200.33--
Genix Pharmaceuticals Corp10.83k-4.23m2.96m--------273.25-0.0714-0.07140.0002-0.02020.00490.05021.89---191.99-54.69-476.20-68.5923.08---39,036.01-5,345.880.0541-10.33-------50.60-309.27------
Lifeist Wellness Inc20.67m-13.27m2.97m72.00--2.68--0.1437-0.0255-0.02550.04060.00191.353.766.14---86.38-62.71-207.88-78.8131.6317.06-64.21-136.110.4947-907.570.5204---1.85--24.45------
Entourage Health Corp40.71m-46.17m3.07m251.00------0.0754-0.150-0.1500.1324-0.47761.052.8412.12---118.59-55.14---150.9213.37-40.59-113.40-199.990.0893-0.807311.31---0.43838.6262.51---49.49--
Quest PharmaTech Inc0.00-22.26m3.38m0.00--0.0511-----0.1319-0.13190.000.39130.00-------28.4623.29-28.8627.25-----------0.05550.0149------91.38------
Hemostemix Inc0.00-2.50m3.48m-----------0.0303-0.03030.00-0.08460.00-------642.29-599.98---------------3.99--------52.21------
Marvel Biosciences Corp0.00-2.51m3.58m-----------0.0632-0.06320.00-0.06170.00-------372.25-----------------26.43--------10.29------
Eve & Co Inc7.77m-5.92m3.74m--------0.4814-0.2055-0.20550.26980.7330.15190.74938.73---11.58---24.24---3.10---76.22--0.062-5.050.4892--2.94---71.97------
Appili Therapeutics Inc1.15m-5.34m4.24m8.00------3.69-0.044-0.0440.0095-0.08110.5047--2.12---234.31-117.41---173.66-----464.23-3,037.15---5.32-----75.97--63.20---43.04--
Data as of May 16 2024. Currency figures normalised to Quest Pharmatech Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.